Mapping evidence on the regulations affecting accessibility, availability and management of snake antivenom globally: a scoping review protocol
Introduction Snakebite envenomation has been declared a neglected tropical disease by the WHO since 2017. The disease is endemic in affected areas due to the lack of availability and access to antivenom, despite it being the standard treatment for snakebites. This challenge is perpetuated by the sho...
Saved in:
Main Authors: | Kabelo Kgarosi, Ramsha Majeed, Janette Bester, Morné Strydom |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-12-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/14/12/e086964.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Spatial Accessibility Analysis of Snake Antivenom
by: Wenjie Hao, et al.
Published: (2025-01-01) -
Hydrocortisone for Preventing Adverse Drug Reactions to Snake Antivenom: A Meta-Analysis
by: Jihua Feng, et al.
Published: (2022-01-01) -
First Look at the Venoms of Two <i>Sinomicrurus</i> Snakes: Differences in Yield, Proteomic Profiles, and Immunorecognition by Commercial Antivenoms
by: Xiang-Yu Li, et al.
Published: (2025-01-01) -
From fangs to antidotes: A scoping review on snakebite burden, species, and antivenoms in the Eastern Mediterranean Region.
by: Ali Alshalah, et al.
Published: (2024-07-01) -
Evidence mapping on barriers in accessing prenatal healthcare services among homeless women: a scoping review
by: Monsurat Adepeju Lateef, et al.
Published: (2025-01-01)